About 30% of individuals with inflammatory bowel disease present before the age of 21 years (1). Despite this prevalence, most therapeutic agents are tested in adults with inflammatory bowel disease and pharmacokinetics, safety, and efficacy may never be studied in children and adolescents. In this
Checklist for US of the bowel in children with inflammatory bowel disease
โ Scribed by Kassa Darge; Sudha Anupindi
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 134 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0301-0449
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The causes of exacerbations of inflammatory bowel disease (IBD) are unknown. The presence of RNA of an enterovirus, norovirus GI, norovirus GII, rotavirus, astrovirus, and sapovirus was sought in stool samples of 50 children (median age 12.9 years) undergoing gastrointestinal endoscopie
## Background: Decreased bone mass is common in children with inflammatory bowel disease (ibd); however, fracture risk is unknown. we sought to evaluate fracture risk in children with ibd as compared to unaffected controls and determine whether this risk is affected by geographical region (a proxy
: We sought to characterize the incidence, nature, and course of liver disease in children with inflammatory bowel disease (IBD). Chart review identified 555 subjects (318 Crohn's disease [CD], 237 ulcerative colitis [UC]). An alanine aminotransferase measurement of โฅ80 U/L was used to identify the